NGM Biopharmaceuticals

$23.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (+0.56%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell NGM and other stocks, options, and ETFs commission-free!

About NGM

NGM Biopharmaceuticals, Inc. Common Stock, also called NGM Biopharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its portfolio include aldafermin (NGM282), NGM313, NGM120, NGM217, NGM621, and NGM395. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA. The listed name for NGM is NGM Biopharmaceuticals, Inc. Common Stock.

CEO
David J. Woodhouse
Employees
186
Headquarters
South San Francisco, California
Founded
2008
Market Cap
1.62B
Price-Earnings Ratio
Dividend Yield
Average Volume
162.27K
High Today
$24.24
Low Today
$23.00
Open Price
$23.60
Volume
165.62K
52 Week High
$24.24
52 Week Low
$9.25

Collections

NGM Earnings

-$1.21
-$0.81
-$0.40
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.43 per share

You May Also Like